February 12, 2021
Dexcom launches diabetes-focused venture capital fund
Documentaries, videos and podcasts
October 13, 2021
After receiving an FDA green light for the project earlier this year, Dexcom is now making its diabetes data available through consumer electronic devices.
September 13, 2021
About four months after the abrupt exit of CEO Mike Coyle, a new leader is taking the helm at cardiac monitor maker iRhythm Technologies.
July 16, 2021
After working to make its continuous glucose monitors compatible with the major players in the diabetes device industry, Dexcom is opening its doors much wider, with new data partnerships with third-party developers.
June 7, 2021
Dexcom accelerated the development of the newest version of its mainstay continuous glucose monitor, and delivered new clinical data showing that CGM systems can provide significant benefits to patients with Type 2 diabetes.
May 6, 2021
The upcoming pen will work with glucose monitoring sensors, digital health programs and other tools from Roche, Dexcom, Glooko and myDiabby Healthcare.